Alkermes (ALKS) EBT Margin (2010 - 2026)

Alkermes (ALKS) reported EBT Margin of 156.77% for Q1 2026, down 16509.0% year-over-year from N/an in Q1 2025, and down 1098.51% quarter-over-quarter from 15.7% in Q4 2025.

Alkermes (ALKS) EBT Margin (2010 - 2026) Analysis & Trends

Alkermes (ALKS) has 17 years of EBT Margin data on file, last reported at 156.77% in Q1 2026.

  • EBT Margin for Q1 2026 came in at 156.77%, down 16509.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 16.88% (down 1102.0% YoY), and the FY2025 annual result was 19.75%, down 874.0% from the prior year.
  • EBT Margin declined to 156.77% in Q1 2026 per ALKS's latest filing, from 15.7% in the prior quarter.
  • Over five years, EBT Margin peaked at 45.65% in Q2 2023 and troughed at 2105.25% in Q3 2022.
  • A 5-year average of 177.09% and a median of 15.7% in 2025 frame the typical range for EBT Margin.
  • The sharpest annual moves came in 2022 and 2023: EBT Margin tumbled 209623 bps in 2022, then soared 212959 bps in 2023.
  • A 5-year view of EBT Margin shows it stood at 37.58% in 2022, then plunged by 59 bps to 15.45% in 2023, then soared by 156 bps to 39.51% in 2024, then plunged by 60 bps to 15.7% in 2025, then plunged by 1099 bps to 156.77% in 2026.
  • Business Quant data shows ALKS's EBT Margin at 156.77% in Q1 2026, 15.7% in Q4 2025, and 25.56% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 10.97%
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 33.51%
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 40.73%
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 25.87%
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 30.30%
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 6.35%
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -156.77%
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 41.45%
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -16.70%
10 Liquidia 5.63 Bn 5.40 Bn 121.79 Mn 42.74%

Historic Data

Download Data
DateValue
Mar 31, 2026 -156.77%
Dec 31, 2025 15.70%
Sep 30, 2025 25.56%
Jun 30, 2025 26.84%
Mar 31, 2025 8.32%
Dec 31, 2024 39.51%
Sep 30, 2024 29.15%
Jun 30, 2024 29.24%
Mar 31, 2024 13.39%
Dec 31, 2023 15.45%
Sep 30, 2023 24.34%
Jun 30, 2023 45.65%
Mar 31, 2023 -3.94%
Dec 31, 2022 37.58%
Sep 30, 2022 -2,105.25%
Jun 30, 2022 -1,039.06%
Mar 31, 2022 -16.15%
Dec 31, 2021 39.22%
Sep 30, 2021 -9.02%
Jun 30, 2021 1.86%